US Patent 7345054 Heterocyclic inhibitors of ERK2 and uses thereof
Patent 7345054 was granted and assigned to Vertex Pharmaceuticals on March, 2008 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
March 10, 2005
Date of Patent
March 18, 2008
Patent Application Number
11077188
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 7345054 Heterocyclic inhibitors of ERK2 and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
